Skip to content

Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus

Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus; A Retrospective Non-Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06498570
Enrollment
23
Registered
2024-07-12
Start date
2022-01-01
Completion date
2024-01-10
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cornea Ectasia

Brief summary

Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus

Detailed description

a retrospective non- randomized controlled clinical study. The study included twenty-three grade 3 keratoconic eyes of twenty-three patients, the keratoconus staging was based on Amsler-Krumeich classification The ICRS surgery was performed with the patient under topical anesthesia. A tunnel channel was created by femtosecond laser using a 60-kHz infrared neodymium glass femtosecond laser at a wavelength of 1053 nm (Abbott Laboratories Inc., Abbott Park, Illinois, USA). Two symmetrical kerarings (Mediphacos Inc., Belo Horizonte, Brazil), were implanted in all cases with 160° arc and 0.25, 0.30 mm according to corneal thickness in implantation site. After surgery, the patients had a full ocular evaluation on days 1, 7, and 14, and again after a month. For a period of 1-year, corneal topography readings were taken quarterly.

Interventions

DEVICEIntracorneal rings

The (ICRS), intracorneal rings segments implantation surgery

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* stable keratoconus. * corneal cross-linking performed at least 6 months. * contact lens intolerance * minimum corneal thickness of 350 μm at the thinnest point (TP) * mean keratometry (K mean) value less than 59 D

Exclusion criteria

* any other associated ocular or systemic pathology could affect the vision.

Design outcomes

Primary

MeasureTime frameDescription
K1 and K2 post-operative by Pentacamone yearFlat and Steep K in Diopter post ring implantation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026